Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tecnimede Group is a privately held Portuguese pharmaceutical group focused on the full lifecycle of human medicines, spanning research, development, manufacturing, promotion, and distribution. Founded in 1980, it has grown into one of the largest Portuguese pharmaceutical groups, with direct operations in Portugal, Spain, Italy, Morocco, Brazil, and Colombia and commercial reach into more than 100 markets. The company emphasizes branded and generic medicines, value-added medicines, and internal R&D, with stated priorities that include cell therapy, neuropathic pain, and anti-infectives. Tecnimede also operates production facilities in Portugal and Morocco and maintains a broad marketed portfolio supported by thousands of marketing authorizations worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tecnimede Group.